Modification of the HER2/neu-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes

Yoshiyuki Tanaka, Keith D. Amos, Hong Gu Joo, Timothy J. Eberlein, Peter S. Goedegebuure

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Modification of the HER2/neu-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes'. Together they form a unique fingerprint.

Medicine & Life Sciences